MedPage Today on MSN
Next-Gen Nerve Stimulator Approved for Obstructive Sleep Apnea
Device will not carry concentric collapse contraindication or warning language ...
Woman's World on MSN
Could a sleep apnea pill replace your CPAP machine? New study is promising
A continuous positive airway pressure device is the gold standard for sleep apnea, but it can feel cumbersome and cause dry ...
Right-size your expectations.
A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of ...
Green Matters on MSN
Sleep apnea sufferers may soon be able to reach for a pill to deal with their condition
Researchers believe that a drug used to treat childhood epilepsy may also be good for assisting with sleep apnea-related ...
Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...
A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.
A potential sleep apnea pill, heart-healthy habits for kids, and the surprising mental health effects of March Madness — here ...
People with untreated obstructive sleep apnea (OSA) are more likely to develop Parkinson’s disease than people without OSA, according to a new study. The good news is that the increased risk of ...
Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.
Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results